Roberts, Glore & Co’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$221K Sell
1,232
-448
-27% -$76.5K 0.06% 203
2025
Q4
$238K Buy
+1,680
New +$191K 0.06% 196
2025
Q1
Sell
-2,883
Closed -$248K 202
2024
Q4
$248K Sell
2,883
-203
-7% -$20.2K 0.07% 185
2024
Q3
$292K Buy
3,086
+314
+11% +$27.9K 0.08% 173
2024
Q2
$265K Buy
2,772
+421
+18% +$50.1K 0.08% 176
2024
Q1
$310K Buy
2,351
+298
+15% +$36.7K 0.09% 163
2023
Q4
$297K Buy
+2,053
New +$282K 0.09% 163

Other funds holding ALB

Roberts, Glore & Co's ALB Position: Q1 2026 in Review

Roberts, Glore & Co reduced its Albemarle (ALB) stake by 27% in Q1 2026, selling an estimated $76.5K and leaving 1,232 shares worth $221K. The position accounts for 0.06% of the portfolio, ranked #203.

Roberts, Glore & Co first reported a position in ALB in Q4 2023 and has held it in 7 quarters since. The position peaked at $310K in Q1 2024. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • Roberts, Glore & Co held 1,232 shares of Albemarle worth $221K as of Q1 2026.
  • Roberts, Glore & Co sold 448 Albemarle shares in Q1 2026, an estimated $76.5K.
  • Albemarle made up 0.06% of Roberts, Glore & Co's portfolio in Q1 2026, its #203 holding.
  • Roberts, Glore & Co first reported a position in Albemarle in Q4 2023 and has held it in 7 quarters since.
  • Roberts, Glore & Co's Albemarle position peaked at $310K in Q1 2024.
  • 982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Roberts, Glore & Co's 13F filing for Q1 2026, filed 4 May 2026.